𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia–lymphoma

✍ Scribed by Kohji Ezaki; Masami Hirano; Ryuzo Ohno; Kazumasa Yamada; Kazuyuk Naito; Yutak Hirota; Shiger Shirakawa; Kiyoji Kimura

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
399 KB
Volume
68
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular cloning and analysis of a new
Molecular cloning and analysis of a new variant of human T-cell leukemia virus (HTLV-Ib) from an African patient with adult T-cell leukemia-lymphoma
✍ Beatrice H. Hahn; George M. Shaw; Mikulas Popovic; Anita Lo Monico; Robert C. Ga 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 655 KB

We report the identification and characterization of a new variant of HTLV-I in an African patient with adult T-cell leukemia/lymphoma (ATL). Proviral sequences were detected by Southern blot analysis in three T-cell lines established from this patient's peripheral blood lymphocytes (PBL) and lymph-

Modelling the risk of adult T-cell leuke
Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I
✍ E. L. Murphy; B. Hanchard; J. P. Figueroa; W. N. Gibbs; W. S. Lofters; M. Campbe 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 434 KB 👁 2 views

Adult T-cell leukernidlymphoma (ATL), a malignancy of mature CDCpositive lymphocytes, has been etiologically linked to the human retrovirus HTLV-I. Although a long latent period is suggested from migrant studies, little prospective information on the risk of developing ATL among persons with HTLV-I

Hemophagocytic syndrome as a presenting
Hemophagocytic syndrome as a presenting sign of transformation of smoldering to acute adult T-cell leukemia/lymphoma: Efficacy of anti-retroviral and interferon therapy
✍ Achille Aouba; Olivier Lambotte; Viorel Vasiliu; Marine Divine; Françoise Valens 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract A 55‐year‐old Caribbean woman with a 6‐year history of smoldering adult T‐cell leukemia/lymphoma presented with clinical and biological symptoms of hemophagocytic syndrome. An extensive search for infectious diseases was negative. A lymph node biopsy showing large T‐cell lymphoma (CD4^−

Human T-cell lymphotropic virus type I (
Human T-cell lymphotropic virus type I (HTLV-I) antibodies in pre-diagnostic serum of patients with familial adult T-cell leukemia/lymphoma (ATL)
✍ Abraham M. Y. Nomura; Eugene T. Yanagihara; William A. Blattner; Gloria Y. F. Ho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English

## Abstract In a study of 7498 American men of Japanese ancestry in Hawaii, 26 incident cases of leukemia or non‐Hodgkin's lymphoma were identified after a follow‐up period of 19 years. Two of the cases, who were brothers, were diagnosed with adult T‐cell leukemia/lymphoma (ATL). Both of these brot

Results of a Phase II trial of oral bexa
Results of a Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma
✍ David J. Straus; Madeleine Duvic; Timothy Kuzel; Steven Horwitz; Marie-France De 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

## Abstract ## BACKGROUND. Bexarotene is one of the most active single agents for the treatment of recurring or refractory cutaneous T‐cell lymphoma (CTCL). Interferon alfa has also been used for many years as an effective treatment for this disease. The results in recent case reports of the combi